|
Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309) |
|
|
|
Titel: |
Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309) |
Auteur: |
Yang, Yunpeng Pan, Jianji Wang, Hui Zhao, Yuanyuan Qu, Shenhong Chen, Nianyong Chen, Xiaozhong Sun, Yan He, Xiaohui Hu, Chaosu Lin, Lizhu Yu, Qitao Wang, Siyang Wang, Guihua Lei, Feng Wen, Jiyu Yang, Kunyu Lin, Zhixiong Guo, Ye Chen, Shaoqing Huang, Xiaoming Wu, Yanjie Liang, Liang Chen, Chenqi Bai, Fan Ma, Xiaopeng Zhang, Yun Leaw, Shiangjiin Zhang, Li Fang, Wenfeng |
Verschenen in: |
Cancer cell |
Paginering: |
Jaargang 41 () nr. 6 pagina's 1061-1072.e4 |
Jaar: |
2023 |
Inhoud: |
|
Uitgever: |
The Authors |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|